Report cover image

Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027

Publisher GlobalData
Published Mar 07, 2022
Length 41 Pages
SKU # GBDT17095337

Description

Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027

Summary

This reports provides a data-driven overview of the current and future competitive landscape in osteosarcoma therapeutics.

In osteosarcoma Cells expressing ganglioside GD2 is a major focus of drug developers. There are 131 drugs in the pipeline with 98% molecules present in early-to-mid stage. Mid-sized Pharma dominates clinical development in this space. More frequent use of newer symptomatic treatments are expected to drive the market. However, the market growth is limited by higher usage of generic medicines, and due to high cost associated with osteosarcoma therapies.

Scope

GlobalData’s Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027 combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include -
  • Disease epidemiology
  • Marketed drugs assessment
  • Pipeline drugs assessment
  • Clinical trials assessment
  • Commercial assessment
Reasons to Buy
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the osteosarcoma market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global osteosarcoma market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

41 Pages
  • Key Findings
    • Report Scope
    • Disease Overview
    • Epidemiology Overview: Diagnosed Prevalence of Osteosarcoma in 2021
    • Marketed Drugs Overview
    • Pipeline Overview
    • Pipeline Products - Breakdown by Region
    • Global Pipeline Products - Target/Mechanism of Action Breakdown
    • Pipeline Products - Review Designations
    • Global Osteosarcoma Pipeline Products - Phase Transition Success Rates
    • Global Osteosarcoma Pipeline Products - Likelihood of Approval
    • Global Clinical Trials - Overview by Status and Phase
    • Clinical Trials - Overview by Region
    • Clinical Trials - Therapy Area Perspective
    • Global Clinical Trials - Leading Sponsors
    • Global Clinical Trials - Enrollment Analytics
    • Global Clinical Trials - Enrollment Analytics, Overview by Region
    • Global Clinical Trials - Feasibility Analysis: Comparison of Leading Late-Stage Trial Designs
    • Clinical Trials - Feasibility Analysis: Geography Overview
    • Commercial Assessment - Upcoming Market Catalysts
    • Methodology
    • About the Authors
    • Contact Us - A Global Network of Offices

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us